Literature DB >> 20028964

Emerging role of neuregulin as a modulator of muscle metabolism.

Anna Gumà1, Vicente Martínez-Redondo, Iliana López-Soldado, Carles Cantó, Antonio Zorzano.   

Abstract

Neuregulin was described initially as a neurotrophic factor involved in the formation of the neuromuscular junction in skeletal muscle. However, in recent years, neuregulin has been reported to be a myokine that exerts relevant effects on myogenesis and the regulation of muscle metabolism. In this new context, the rapid and chronic metabolic effects of neuregulin appear to be related to muscle contraction. Indeed, the effects of neuregulin resemble those of exercise, which are accompanied by an improvement in insulin sensitivity. In this review, we challenge the classical role assigned to neuregulin in muscle and propound the emerging concept of its involvement in the regulation of energetic metabolism and insulin responsiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028964     DOI: 10.1152/ajpendo.00541.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  29 in total

1.  Exercise training and return to a well-balanced diet activate the neuregulin 1/ErbB pathway in skeletal muscle of obese rats.

Authors:  Gaël Ennequin; Nathalie Boisseau; Kevin Caillaud; Vivien Chavanelle; Maude Gerbaix; Lore Metz; Monique Etienne; Stéphane Walrand; Aurélie Masgrau; Christelle Guillet; Daniel Courteix; Airu Niu; Yi-Ping Li; Fréderic Capel; Pascal Sirvent
Journal:  J Physiol       Date:  2015-05-14       Impact factor: 5.182

2.  Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure.

Authors:  Zhihong Huang; Douglas B Sawyer; Erika L Troy; Corissa McEwen; John H Cleator; Abigail Murphy; Anthony O Caggiano; Andrew Eisen; Tom J Parry
Journal:  Toxicol Appl Pharmacol       Date:  2017-08-02       Impact factor: 4.219

Review 3.  Age-associated alterations of the neuromuscular junction.

Authors:  Youngmok C Jang; Holly Van Remmen
Journal:  Exp Gerontol       Date:  2010-09-18       Impact factor: 4.032

4.  Hypoxia pretreatment improves the therapeutic potential of bone marrow mesenchymal stem cells in hindlimb ischemia via upregulation of NRG-1.

Authors:  Xitao Peng; Bing Liang; Haisheng Wang; Jingyuan Hou; Qidong Yuan
Journal:  Cell Tissue Res       Date:  2022-01-29       Impact factor: 5.249

Review 5.  Running forward: new frontiers in endurance exercise biology.

Authors:  Glenn C Rowe; Adeel Safdar; Zolt Arany
Journal:  Circulation       Date:  2014-02-18       Impact factor: 29.690

Review 6.  Neuregulin as a heart failure therapy and mediator of reverse remodeling.

Authors:  Cristi L Galindo; Sergey Ryzhov; Douglas B Sawyer
Journal:  Curr Heart Fail Rep       Date:  2014-03

7.  Dysregulation of Amphiregulin stimulates the pathogenesis of cystic lymphangioma.

Authors:  Naofumi Yoshida; Seiji Yamamoto; Takeru Hamashima; Noriko Okuno; Naruho Okita; Shinjiro Horikawa; Masao Hayashi; Thanh Chung Dang; Quang Linh Nguyen; Koichi Nishiyama; Teruhiko Makino; Yoko Ishii; Kei Tomihara; Tadamichi Shimizu; Masabumi Shibuya; Makoto Noguchi; Masakiyo Sasahara
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

8.  NRG4-ErbB4 signaling represses proinflammatory macrophage activity.

Authors:  Michael A Schumacher; Isabella C Dennis; Cambrian Y Liu; Cache Robinson; Judie Shang; Jessica K Bernard; M Kay Washington; D Brent Polk; Mark R Frey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-04-07       Impact factor: 4.871

9.  Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies.

Authors:  David Montaigne; Christopher Hurt; Remi Neviere
Journal:  Biochem Res Int       Date:  2012-03-20

10.  Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers.

Authors:  Igor Odintsov; Marissa S Mattar; Allan J W Lui; Michael Offin; Christopher Kurzatkowski; Lukas Delasos; Inna Khodos; Marina Asher; Robert M Daly; Natasha Rekhtman; Elisa de Stanchina; Gopinath Ganji; Marc Ladanyi; Romel Somwar
Journal:  J Thorac Oncol       Date:  2021-04-08       Impact factor: 20.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.